Targeting platelet-derived soluble CD40 ligand: a new treatment strategy for HIV-associated neuroinflammation?

Human immunodeficiency virus type 1 (HIV) continues to be one of the most prevalent global health afflictions to date. The advent and introduction of combined antiretroviral therapy (cART) has made a significant impact on the course of infection. However, as patients are living longer, many HIV-asso...

Descripción completa

Detalles Bibliográficos
Autores principales: Davidson, Donna C, Jackson, Joseph W, Maggirwar, Sanjay B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906985/
https://www.ncbi.nlm.nih.gov/pubmed/24289660
http://dx.doi.org/10.1186/1742-2094-10-144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906985/
https://www.ncbi.nlm.nih.gov/pubmed/24289660
http://dx.doi.org/10.1186/1742-2094-10-144

Ejemplares similares